XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Convertible And Redeemable Series A-2 Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance at Dec. 31, 2021 $ 316,501     $ 464,143 $ (147,678) $ 36
Beginning balance, shares at Dec. 31, 2021     29,619,921      
Beginning balance at Dec. 31, 2021   $ 152,928        
Beginning balance, shares at Dec. 31, 2021   17,500        
Net loss (7,536)       (7,536)  
Stock-based compensation 10,425     10,425    
Dividend payment to the Series A-2 preferred shareholders (4,100) $ (4,100)   (4,100)    
Common stock issued $ 429     429    
Common stock issued, shares 55,896   55,896      
Accumulated other comprehensive income $ 45         45
Ending balance at Mar. 31, 2022 315,764     470,897 (155,214) 81
Ending balance, shares at Mar. 31, 2022   17,500        
Ending balance at Mar. 31, 2022   $ 152,928        
Ending balance, shares at Mar. 31, 2022     29,675,817      
Beginning balance at Dec. 31, 2022 313,187     492,676 (179,497) 8
Beginning balance, shares at Dec. 31, 2022     29,746,793      
Beginning balance at Dec. 31, 2022   $ 152,928        
Beginning balance, shares at Dec. 31, 2022   17,500        
Net loss (14,719)       (14,719)  
Stock-based compensation 13,035     13,035    
Dividend payment to the Series A-2 preferred shareholders (4,100) $ (4,100)   (4,100)    
Common stock issued $ 2,690     2,690    
Common stock issued, shares 214,571   214,571      
Accumulated other comprehensive income $ 12         12
Ending balance at Mar. 31, 2023 $ 310,105     $ 504,301 $ (194,216) $ 20
Ending balance, shares at Mar. 31, 2023   17,500        
Ending balance at Mar. 31, 2023   $ 152,928        
Ending balance, shares at Mar. 31, 2023     29,961,364